A 42-year-old man with a 10-year history of asthma presents with a pruritic, erythematous rash on his forearms and neck that began 8 days after starting oral amoxicillin for a respiratory tract infection. He reports fever (38.2°C), generalized malaise, and mild joint pain in both knees. Laboratory investigations show: WBC 11,500/μL with 8% eosinophils, ESR 42 mm/hr. Skin biopsy shows perivascular lymphocytic infiltration with fibrinoid necrosis of small blood vessels. What is the primary immunological mechanism responsible for this clinical presentation?

Explanation

## Type III Hypersensitivity: Immune Complex Disease This clinical vignette exemplifies **Type III hypersensitivity (immune complex-mediated reaction)**, specifically a serum sickness-like reaction to amoxicillin. ### Temporal and Clinical Hallmarks **Key Point:** Type III hypersensitivity typically manifests **7–14 days after drug exposure**, distinguishing it from the immediate (Type I) and delayed (Type IV) reactions. ### Pathogenic Mechanism 1. **Antigen-antibody complex formation**: Drug (amoxicillin) acts as hapten → binds to serum proteins → forms drug-protein conjugate → triggers IgG and IgM antibody production 2. **Immune complex deposition**: Circulating antigen-antibody complexes deposit in small blood vessels (dermal, articular, renal) 3. **Complement activation**: Immune complexes activate classical complement pathway (C1q binding) → generation of C3a, C5a (anaphylatoxins) → recruitment of neutrophils and macrophages 4. **Tissue inflammation**: Fibrinoid necrosis of vessel walls, vasculitis, and leukocyte infiltration → clinical manifestations ### Clinical Triad of Serum Sickness-Like Reaction | Feature | Mechanism | |---------|----------| | **Rash (urticarial/maculopapular)** | Immune complex deposition in dermal vessels; complement-mediated vasculitis | | **Fever + malaise** | Systemic inflammatory response to immune complex burden | | **Arthralgia/arthritis** | Immune complex deposition in synovial vessels; complement activation | **High-Yield:** The **8-day onset** is the critical diagnostic clue — this timing is pathognomonic for Type III hypersensitivity and rules out Type I (minutes) and Type IV (24–72 hours). ### Histopathological Findings **Clinical Pearl:** Fibrinoid necrosis of small blood vessels with perivascular lymphocytic infiltration is the hallmark histological finding of immune complex vasculitis. This is distinct from: - Type I: mast cell degranulation (no necrosis) - Type IV: lymphocytic infiltration without fibrinoid necrosis ### Laboratory Correlates - **Elevated ESR (42 mm/hr)**: Reflects systemic inflammation and immune complex burden - **Eosinophilia (8%)**: Common in drug hypersensitivity reactions - **Normal complement levels** (if measured): May show transient depression during acute phase due to consumption by immune complexes **Mnemonic: Type III = "3 Cs"** — Circulating immune Complexes, Complement activation, Clinical manifestations at 7–14 days